Publicaciones en las que colabora con Olga López Villar (10)

2014

  1. Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients

    Leukemia Research, Vol. 38, Núm. 10, pp. 1199-1206

  2. Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease

    Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 10, pp. 1580-1585

2012

  1. Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation

    Transfusion, Vol. 52, Núm. 5, pp. 1086-1091

  2. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

    Haematologica, Vol. 97, Núm. 8, pp. 1218-1224

  3. Unidades de producción celular para investigación clínica con células madre: principios básicos para su establecimiento y optimización

    Medicina Clinica, Vol. 138, Núm. 1, pp. 31-36

2011

  1. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: Results of a phase I/II clinical trial

    Haematologica, Vol. 96, Núm. 7, pp. 1072-1076

2009

  1. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

    Leukemia, Vol. 23, Núm. 4, pp. 664-672

  2. C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

    Leukemia Research, Vol. 33, Núm. SUPPL. 1

  3. Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects

    Cell and Tissue Research, Vol. 336, Núm. 3, pp. 501-507

  4. P136 Allogenic stem cell transplant in MDS: results of the Spanish registry

    Leukemia Research, Vol. 33, Núm. SUPPL. 1